J 2022

Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study

BRETSCHNEIDER, Maxi Pia, Jan KLÁSEK, Martina KARBANOVÁ, Patrick TIMPEL, Sandra HERRMANN et. al.

Basic information

Original name

Impact of a Digital Lifestyle Intervention on Diabetes Self-Management: A Pilot Study

Authors

BRETSCHNEIDER, Maxi Pia (276 Germany), Jan KLÁSEK (203 Czech Republic), Martina KARBANOVÁ (203 Czech Republic, belonging to the institution), Patrick TIMPEL (276 Germany), Sandra HERRMANN (276 Germany) and Peter E. H. SCHWARZ (276 Germany)

Edition

Nutrients, Basel, MDPI, 2022, 2072-6643

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30304 Public and environmental health

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.900

RIV identification code

RIV/00216224:14110/22:00125808

Organization unit

Faculty of Medicine

DOI

UT WoS

000794653000001

Keywords in English

diabetes mellitus type 2; self-management; digital health; HbA1c; lifestyle intervention; digital intervention; mHealth

Tags

Tags

International impact, Reviewed
Změněno: 23/1/2023 10:56, Mgr. Tereza Miškechová

Abstract

V originále

The aim of this study was to provide preliminary evidence on the impact of the digital health application Vitadio on improving glycemic control in patients with type 2 diabetes mellitus. This was a 3-month, prospective, multicenter, open-label trial with an intraindividual control group. Participants received a digital lifestyle intervention. HbA1c levels were observed at 3 time points: retrospectively, at 3 months before app use; at baseline, at the start of usage; and 3 months after the start of use. In addition, changes in other metabolic parameters (fasting glucose, body weight, and waist circumference), patient reported outcomes (quality of life, self-efficacy, and depression), and data generated within the app (frequency of use, steps, and photos of meals) were evaluated. Repeated measures analysis of variance with the Bonferroni correction was used to assess the overall difference in HbA1c values between the intervention and the intraindividual control group, with p < 0.05 considered significant. Participants (n = 42) were 57 +/- 7.4 years old, 55% male, and with a mean baseline HbA1c of 7.9 +/- 1.0%. An average HbA1c reduction of -0.9 +/- 1.1% (p < 0.001) was achieved. The digital health application was effective in significantly reducing body weight (-4.3 +/- 4.5 kg), body mass index (-1.4 +/- 1.5 kg/m(2)), waist circumference (-5.7 +/- 15 cm), and fasting glucose (-0.6 +/- 1.3 mmol/L). The digital therapy achieved a clinically meaningful and significant HbA1c reduction as well as a positive effect on metabolic parameters. These results provide preliminary evidence that Vitadio may be effective in supporting patient diabetes management by motivating patients to adopt healthier lifestyles and improving their self-management.